Skip to main content
Top
Published in: Journal of Neuro-Oncology 3/2010

01-02-2010 | Topic Review

Bing–Neel syndrome: an illustrative case and a comprehensive review of the published literature

Authors: Roneil G. Malkani, Martin Tallman, Numa Gottardi-Littell, William Karpus, Laura Marszalek, Daina Variakojis, Bruce Kaden, Matthew Walker, Robert M. Levy, Jeffrey J. Raizer

Published in: Journal of Neuro-Oncology | Issue 3/2010

Login to get access

Abstract

Waldenstrom’s macroglobulinemia (WM) is a chronic lymphoproliferative disorder within the spectrum of lymphoplasmacytic lymphoma characterized by proliferation of plasma cells, small lymphocytes, and plasmacytoid lymphocytes. Central nervous system involvement is very rare (Bing–Neel [BN] syndrome). We present the case of a 62-year-old woman previously diagnosed with WM who presented with Bing–Neel syndrome and review the published literature which consists of only case reports. We performed a Medline search using the terms “Waldenstrom’s macroglobulinemia and central nervous system” and “Bing–Neel” collecting data on presentation, evaluation, treatment, and outcome and summarizing these findings in the largest pooled series to date. Central nervous system manifestations are localization related. Serum laboratory testing reflects systemic disease. Cerebrospinal fluid analysis may show lymphocytic pleocytosis, elevated protein, and IgM kappa or lambda light chain restriction; cytology results are variable. Imaging is frequently abnormal. Biopsy confirms the diagnosis. Treatment data are limited, but responses are seen with radiation and/or chemotherapy. BN syndrome is a very rare complication of WM that should be considered in patients with neurologic symptoms and a history of WM. Treatment should be initiated as responses do occur that may improve quality of life and extend it when limited or no active systemic disease is present.
Literature
1.
go back to reference Swerdlow SH, International Agency for Research on Cancer, World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, France Swerdlow SH, International Agency for Research on Cancer, World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, France
2.
go back to reference Waldenstrom J (1944) Incipient myelomatosis or “essential” hyperglobulinemia with fibrogenopenia: a new syndrome? Acta Med Scand 117:216–247 Waldenstrom J (1944) Incipient myelomatosis or “essential” hyperglobulinemia with fibrogenopenia: a new syndrome? Acta Med Scand 117:216–247
3.
go back to reference Bing J, Neel A (1936) Two cases of hyperglobulinemia with affection of the central nervous system on a toxi-infection bases. Acta Med Scand 88:492–506 Bing J, Neel A (1936) Two cases of hyperglobulinemia with affection of the central nervous system on a toxi-infection bases. Acta Med Scand 88:492–506
4.
go back to reference Vula O, Merhaien P (1972) Cerebral reticuloplasmacytosis with hyperglobulinemia. Its relation to the Bing-Neel syndrome. Eur Neurol 7:155–168CrossRefPubMed Vula O, Merhaien P (1972) Cerebral reticuloplasmacytosis with hyperglobulinemia. Its relation to the Bing-Neel syndrome. Eur Neurol 7:155–168CrossRefPubMed
5.
go back to reference Imai F, Fujisawa K, Kiya N, Ninomiya T, Ogura Y, Mizoguchi Y, Sano H, Kanno T (1995) Intracerebral infiltration by monoclonal plasmacytoid cells in Waldenstrom’s macroglobulinemia—case report. Neurol Med Chir (Tokyo) 35:575–579CrossRef Imai F, Fujisawa K, Kiya N, Ninomiya T, Ogura Y, Mizoguchi Y, Sano H, Kanno T (1995) Intracerebral infiltration by monoclonal plasmacytoid cells in Waldenstrom’s macroglobulinemia—case report. Neurol Med Chir (Tokyo) 35:575–579CrossRef
6.
go back to reference Logothetis J, Silverstein P, Coe J (1960) Neurologic aspects of Waldenstrom’s macroglobulinemia; report of a case. Arch Neurol 3:564–573PubMed Logothetis J, Silverstein P, Coe J (1960) Neurologic aspects of Waldenstrom’s macroglobulinemia; report of a case. Arch Neurol 3:564–573PubMed
7.
go back to reference Edgar R, Dutcher TF (1961) Histopathology of the Bing-Neel syndrome. Neurology 11:239–245PubMed Edgar R, Dutcher TF (1961) Histopathology of the Bing-Neel syndrome. Neurology 11:239–245PubMed
8.
go back to reference Bhatti MT, Yuan C, Winter W, McSwain AS, Okun MS (2005) Bilateral sixth nerve paresis in the Bing-Neel syndrome. Neurology 64:576–577PubMed Bhatti MT, Yuan C, Winter W, McSwain AS, Okun MS (2005) Bilateral sixth nerve paresis in the Bing-Neel syndrome. Neurology 64:576–577PubMed
9.
go back to reference Torrey JJ, Katakkar SB (1984) Treatable meningeal involvement in Waldenstrom’s macroglobulinemia. Ann Intern Med 101:345–347PubMed Torrey JJ, Katakkar SB (1984) Treatable meningeal involvement in Waldenstrom’s macroglobulinemia. Ann Intern Med 101:345–347PubMed
10.
go back to reference Neau JP, Guilhot F, Dumas P, Besson I, Rivasseau-Jonveaux T, Gil R (1991) [Central neurologic forms of Waldenstrom’s disease Bing-Neel syndrome. 3 cases]. Rev Neurol (Paris) 147:56–60 Neau JP, Guilhot F, Dumas P, Besson I, Rivasseau-Jonveaux T, Gil R (1991) [Central neurologic forms of Waldenstrom’s disease Bing-Neel syndrome. 3 cases]. Rev Neurol (Paris) 147:56–60
11.
go back to reference Delgado J, Canales MA, Garcia B, Alvarez-Ferreira J, Garcia-Grande A, Hernandez-Navarro F (2002) Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: case report and review of the literature. Am J Hematol 69:127–131CrossRefPubMed Delgado J, Canales MA, Garcia B, Alvarez-Ferreira J, Garcia-Grande A, Hernandez-Navarro F (2002) Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: case report and review of the literature. Am J Hematol 69:127–131CrossRefPubMed
12.
go back to reference Donix M, Beuthien-Baumann B, von Kummer R, Gahn G, Thomas F, Holthoff V (2007) Nonfluent aphasia in a patient with Waldenstrom’s macroglobulinemia. J Clin Neurosci 14:601–603CrossRefPubMed Donix M, Beuthien-Baumann B, von Kummer R, Gahn G, Thomas F, Holthoff V (2007) Nonfluent aphasia in a patient with Waldenstrom’s macroglobulinemia. J Clin Neurosci 14:601–603CrossRefPubMed
13.
go back to reference Fain O, Wechsler B, Vidailhet M, Raphael M, Schuller E, Godeau P (1992) [Involvement of central nervous system disclosing Waldenstrom’s disease: demonstration of intrathecal secretion of immunoglobulin M]. Rev Med Interne 13:58–60CrossRefPubMed Fain O, Wechsler B, Vidailhet M, Raphael M, Schuller E, Godeau P (1992) [Involvement of central nervous system disclosing Waldenstrom’s disease: demonstration of intrathecal secretion of immunoglobulin M]. Rev Med Interne 13:58–60CrossRefPubMed
14.
go back to reference Garderet L, Baudel JL, Cervera P, Azizi L, Maury E, Guidet B, Gorin NC, Offenstadt G (2006) ‘Indolent’ Waldenstrom’s macroglobulinemia and a cerebrospinal fluid protein level of 16 g/L. Eur J Haematol 77:80–82CrossRefPubMed Garderet L, Baudel JL, Cervera P, Azizi L, Maury E, Guidet B, Gorin NC, Offenstadt G (2006) ‘Indolent’ Waldenstrom’s macroglobulinemia and a cerebrospinal fluid protein level of 16 g/L. Eur J Haematol 77:80–82CrossRefPubMed
15.
go back to reference Welch D, Whetsell WO Jr, Weil RJ (2002) Pathologic quiz case. A man with long-standing monoclonal gammopathy and new onset of confusion. Central nervous system involvement by Waldenstrom macroglobulinemia-Bing-Neel syndrome. Arch Pathol Lab Med 126:1243–1244PubMed Welch D, Whetsell WO Jr, Weil RJ (2002) Pathologic quiz case. A man with long-standing monoclonal gammopathy and new onset of confusion. Central nervous system involvement by Waldenstrom macroglobulinemia-Bing-Neel syndrome. Arch Pathol Lab Med 126:1243–1244PubMed
16.
go back to reference Scheithauer BW, Rubinstein LJ, Herman MM (1984) Leukoencephalopathy in Waldenstrom’s macroglobulinemia. Immunohistochemical and electron microscopic observations. J Neuropathol Exp Neurol 43:408–425CrossRefPubMed Scheithauer BW, Rubinstein LJ, Herman MM (1984) Leukoencephalopathy in Waldenstrom’s macroglobulinemia. Immunohistochemical and electron microscopic observations. J Neuropathol Exp Neurol 43:408–425CrossRefPubMed
17.
go back to reference Weiss AH, Smith E, Christoff N, Kochwa S (1965) Cerebrospinal fluid paraproteins in multiple myeloma. J Lab Clin Med 66:280–293PubMed Weiss AH, Smith E, Christoff N, Kochwa S (1965) Cerebrospinal fluid paraproteins in multiple myeloma. J Lab Clin Med 66:280–293PubMed
18.
go back to reference Frantzen E, Hertz H, Matzke J, Videbaek A (1969) Protein studies on cerebrospinal fluid and neurological symptoms in myelomatosis. Acta Neurol Scand 45:1–17CrossRefPubMed Frantzen E, Hertz H, Matzke J, Videbaek A (1969) Protein studies on cerebrospinal fluid and neurological symptoms in myelomatosis. Acta Neurol Scand 45:1–17CrossRefPubMed
19.
go back to reference Hansotia P, Gani K, Friedenberg W (1983) Cerebrospinal fluid monoclonal gammopathy in multiple myeloma and Waldenstrom’s macroglobulinemia. Neurology 33:1411–1415PubMed Hansotia P, Gani K, Friedenberg W (1983) Cerebrospinal fluid monoclonal gammopathy in multiple myeloma and Waldenstrom’s macroglobulinemia. Neurology 33:1411–1415PubMed
20.
go back to reference Dimopoulos MA, Kantarjian H, Weber D, O’Brien S, Estey E, Delasalle K, Rose E, Cabanillas F, Keating M, Alexanian R (1994) Primary therapy of Waldenstrom’s macroglobulinemia with 2-chlorodeoxyadenosine. J Clin Oncol 12:2694–2698PubMed Dimopoulos MA, Kantarjian H, Weber D, O’Brien S, Estey E, Delasalle K, Rose E, Cabanillas F, Keating M, Alexanian R (1994) Primary therapy of Waldenstrom’s macroglobulinemia with 2-chlorodeoxyadenosine. J Clin Oncol 12:2694–2698PubMed
21.
go back to reference Laurencet FM, Zulian GB, Guetty-Alberto M, Iten PA, Betticher DC, Alberto P (1999) Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies. Br J Cancer 79:1215–1219CrossRefPubMed Laurencet FM, Zulian GB, Guetty-Alberto M, Iten PA, Betticher DC, Alberto P (1999) Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies. Br J Cancer 79:1215–1219CrossRefPubMed
22.
go back to reference Richards AI (1995) Response of meningeal Waldenstrom’s macroglobulinemia to 2-chlorodeoxyadenosine. J Clin Oncol 13:2476PubMed Richards AI (1995) Response of meningeal Waldenstrom’s macroglobulinemia to 2-chlorodeoxyadenosine. J Clin Oncol 13:2476PubMed
23.
go back to reference Dimopoulos MA, Anagnostopoulos A, Kyrtsonis MC, Zervas K, Tsatalas C, Kokkinis G, Repoussis P, Symeonidis A, Delimpasi S, Katodritou E, Vervessou E, Michali E, Pouli A, Gika D, Vassou A, Terpos E, Anagnostopoulos N, Economopoulos T, Pangalis G (2007) Primary treatment of Waldenstrom macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide. J Clin Oncol 25:3344–3349CrossRefPubMed Dimopoulos MA, Anagnostopoulos A, Kyrtsonis MC, Zervas K, Tsatalas C, Kokkinis G, Repoussis P, Symeonidis A, Delimpasi S, Katodritou E, Vervessou E, Michali E, Pouli A, Gika D, Vassou A, Terpos E, Anagnostopoulos N, Economopoulos T, Pangalis G (2007) Primary treatment of Waldenstrom macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide. J Clin Oncol 25:3344–3349CrossRefPubMed
24.
go back to reference Treon SP, Emmanouilides C, Kimby E, Kelliher A, Preffer F, Branagan AR, Anderson KC, Frankel SR (2005) Extended rituximab therapy in Waldenstrom’s macroglobulinemia. Ann Oncol 16:132–138CrossRefPubMed Treon SP, Emmanouilides C, Kimby E, Kelliher A, Preffer F, Branagan AR, Anderson KC, Frankel SR (2005) Extended rituximab therapy in Waldenstrom’s macroglobulinemia. Ann Oncol 16:132–138CrossRefPubMed
25.
go back to reference Weide R, Heymanns J, Koppler H (1999) Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenstrom’s macroglobulinaemia. Leuk Lymphoma 36:203–206CrossRefPubMed Weide R, Heymanns J, Koppler H (1999) Induction of complete haematological remission after monotherapy with anti-CD20 monoclonal antibody (RITUXIMAB) in a patient with alkylating agent resistant Waldenstrom’s macroglobulinaemia. Leuk Lymphoma 36:203–206CrossRefPubMed
26.
go back to reference Weide R, Heymanns J, Koppler H (2000) The polyneuropathy associated with Waldenstrom’s macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximab. Br J Haematol 109:838–841CrossRefPubMed Weide R, Heymanns J, Koppler H (2000) The polyneuropathy associated with Waldenstrom’s macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximab. Br J Haematol 109:838–841CrossRefPubMed
27.
go back to reference Bing J, Fog M, Neel A (1937) Reports of a third case of hyperglobulinemia with affection of the central nervous system on a toxi-infectious basis, and some remarks on the differential diagnosis. Acta Med Scand 91:409–427 Bing J, Fog M, Neel A (1937) Reports of a third case of hyperglobulinemia with affection of the central nervous system on a toxi-infectious basis, and some remarks on the differential diagnosis. Acta Med Scand 91:409–427
28.
go back to reference Tommasi M, Revol L, Schott B, Lesbros F (1966) [Waldenstrom’s macroglobulinemia. Lesions of the central nervous system]. Ann Anat Pathol (Paris) 11:309–313 Tommasi M, Revol L, Schott B, Lesbros F (1966) [Waldenstrom’s macroglobulinemia. Lesions of the central nervous system]. Ann Anat Pathol (Paris) 11:309–313
29.
go back to reference Pennacchio L, Orlandini M (1969) [Immunoglobulin diseases. (Basis of modern immunology. Clinical contribution. Bing-Neel syndrome)]. Policlinico Prat 76:401–422PubMed Pennacchio L, Orlandini M (1969) [Immunoglobulin diseases. (Basis of modern immunology. Clinical contribution. Bing-Neel syndrome)]. Policlinico Prat 76:401–422PubMed
30.
go back to reference Quilichini R, Benderitter T, Lafeuillade A, Chaffanjon P, Aubert L (1989) [Waldenstrom’s macroglobulinemia with cerebral lymphoproliferative involvement of tumor appearance (Bing and Neel syndrome). An anatomo-clinical case]. Ann Med Interne (Paris) 140:25–29 Quilichini R, Benderitter T, Lafeuillade A, Chaffanjon P, Aubert L (1989) [Waldenstrom’s macroglobulinemia with cerebral lymphoproliferative involvement of tumor appearance (Bing and Neel syndrome). An anatomo-clinical case]. Ann Med Interne (Paris) 140:25–29
31.
go back to reference Jammes T, Mann C, Delhom E, Bertrand P, Berthelemy C, Oweini K, Jonquet O (1990) [Bing-Neel syndrome revealed by normal pressure hydrocephalus. Unusual clinical/course of Waldenstrom disease]. Presse Med 19:1992PubMed Jammes T, Mann C, Delhom E, Bertrand P, Berthelemy C, Oweini K, Jonquet O (1990) [Bing-Neel syndrome revealed by normal pressure hydrocephalus. Unusual clinical/course of Waldenstrom disease]. Presse Med 19:1992PubMed
32.
go back to reference Shimizu K, Fujisawa K, Yamamoto H, Mizoguchi Y, Hara K (1993) Importance of central nervous system involvement by neoplastic cells in a patient with Waldenstrom’s macroglobulinemia developing neurologic abnormalities. Acta Haematol 90:206–208CrossRefPubMed Shimizu K, Fujisawa K, Yamamoto H, Mizoguchi Y, Hara K (1993) Importance of central nervous system involvement by neoplastic cells in a patient with Waldenstrom’s macroglobulinemia developing neurologic abnormalities. Acta Haematol 90:206–208CrossRefPubMed
33.
go back to reference Civit T, Coulbois S, Baylac F, Taillandier L, Auque J (1997) [Waldenstrom’s macroglobulinemia and cerebral lymphoplasmocytic proliferation: Bing and Neel syndrome. Apropos of a new case]. Neurochirurgie 43:245–249PubMed Civit T, Coulbois S, Baylac F, Taillandier L, Auque J (1997) [Waldenstrom’s macroglobulinemia and cerebral lymphoplasmocytic proliferation: Bing and Neel syndrome. Apropos of a new case]. Neurochirurgie 43:245–249PubMed
34.
go back to reference Arias M, Pereiro Zabala I, Requena Caballero I, Sesar Ignacio A, Arias Rivas S, Villamayor Blanco B (2004) [Rapidly progressing dementia as the presenting symptom of Waldenstrom’s macroglobulinemia: findings from magnetic resonance imaging of the brain in Bing Neel syndrome]. Rev Neurol 38:640–642PubMed Arias M, Pereiro Zabala I, Requena Caballero I, Sesar Ignacio A, Arias Rivas S, Villamayor Blanco B (2004) [Rapidly progressing dementia as the presenting symptom of Waldenstrom’s macroglobulinemia: findings from magnetic resonance imaging of the brain in Bing Neel syndrome]. Rev Neurol 38:640–642PubMed
35.
go back to reference Kim HD, Shin KC, Cho HS, Kim MK, Lee KH, Hyun MS (2007) Therapeutic experience of Bing-Neel syndrome associated with Waldenstrom’s macroglobulinemia. J Korean Med Sci 22:1079–1081CrossRefPubMed Kim HD, Shin KC, Cho HS, Kim MK, Lee KH, Hyun MS (2007) Therapeutic experience of Bing-Neel syndrome associated with Waldenstrom’s macroglobulinemia. J Korean Med Sci 22:1079–1081CrossRefPubMed
36.
go back to reference Drappatz J, Akar S, Fisher DC, Samuels MA, Kesari S (2008) Imaging of Bing-Neel syndrome. Neurology 70:1364CrossRefPubMed Drappatz J, Akar S, Fisher DC, Samuels MA, Kesari S (2008) Imaging of Bing-Neel syndrome. Neurology 70:1364CrossRefPubMed
Metadata
Title
Bing–Neel syndrome: an illustrative case and a comprehensive review of the published literature
Authors
Roneil G. Malkani
Martin Tallman
Numa Gottardi-Littell
William Karpus
Laura Marszalek
Daina Variakojis
Bruce Kaden
Matthew Walker
Robert M. Levy
Jeffrey J. Raizer
Publication date
01-02-2010
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2010
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-009-9968-3

Other articles of this Issue 3/2010

Journal of Neuro-Oncology 3/2010 Go to the issue